Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL111P is a human pseudogene related to the functional 7SL RNA gene, a component of the signal recognition particle (SRP) complex. The majority of 7SL-related loci in the human genome are pseudogenes, generated by retrotransposition of the functional 7SL RNA[4][1]. RN7SL111P is a truncated, non-expressed derivative and does not encode a functional RNA or protein product, thus has no known biological function or therapeutic relevance[4][1]. The functional 7SL RNA participates in co-translational protein targeting via the SRP complex[3][5][6], but pseudogenes like RN7SL111P do not contribute to these processes. RN7SL111P is a genetic locus defined as a pseudogene, not a protein, receptor, enzyme, or RNA with physiological function. It should not be considered a valid therapeutic target. If you require information on the functional SRP RNA or related molecules (such as RN7SL1), those could have biological function and disease relevance[3][5][6], but not this pseudogene.
Null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 111, pseudogene (RN7SL111P).